Immunoterapia del melanoma e terapie adiuvanti

Translated title of the contribution: Immunotherapy of malignant melanoma and adjuvant therapies

R. A. Satriano, F. Di Girolamo, P. A. Ascierto, S. Scala, A. Ottaiano, G. Castello, V. Ruocco

Research output: Contribution to journalArticlepeer-review

Abstract

Biotherapies, including immunotherapy, are a field of great interest in the treatment of malignant melanoma and many new approaches have been proposed in the last years. The aim of this paper is to review the literature on immunotherapies (vaccines, cytokines, adjuvant immunotherapies) in the treatment of malignant melanoma. There is a wide diversity in contents and quality of studies. Frequently, the therapies are proposed for advanced disease as the "last chance" for the patients. Hopefully, quality of the studies could be improved by selecting a priori patients bearing a particular target with not heavily pretreated disease and by evaluating biological end-points.

Translated title of the contributionImmunotherapy of malignant melanoma and adjuvant therapies
Original languageItalian
Pages (from-to)97-109
Number of pages13
JournalGiornale Italiano di Dermatologia e Venereologia
Volume139
Issue number2
Publication statusPublished - 2004

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Immunotherapy of malignant melanoma and adjuvant therapies'. Together they form a unique fingerprint.

Cite this